Major pharma companies increase mifepristone production within 12 months of restrictive ruling

Drugmakers would respond to potential supply shortages by ramping up production or exploring alternative formulations. Pfizer and Danco Laboratories would announce capacity expansions or new partnerships to meet demand in restricted markets.

Implied probability (Yes)

55%